Disease name

질식성 가슴 형성이상[쥐느]
 Asphyxiating thoracic dysplasia [Jeune]

Marker gene

Gene symbol Chromosome location Protein name
DYNC2H1 11q22.3 Cytoplasmic dynein 2 heavy chain 1
IFT80 3q25.33 Intraflagellar transport protein 80 homolog

Prevalence

1-9 / 1 000 000

Inheritance

상염색체 열성

Age of onset

신생아기, 영아기

ICD 10 code

Q77.2

MIM number

208500
611263
613091

Synonym

Asphyxiating thoracic dystrophy of the newborn

Summary

Jeune syndrome, also called asphyxiating thoracic dystrophy, is a short-rib dysplasia characterized by a narrow thorax and short limbs. Incidence at birth is 1-5/500,000. The syndrome is recognizable at birth. In some cases, postaxial polydactyly may also be present. The narrow thorax may cause respiratory failure, even in the neonatal period, and may be associated with persistent respiratory manifestations. Some cases are severe while others have a benign development. Affected children display near normal growth. Hepatic cholestasis has been reported in some rare cases and polycystic or tubulointerstitial nephritis may occur at any age. The syndrome is transmitted as an autosomal recessive trait. A causative gene has been mapped to the 15q13 locus in some families but mutations in the IFT80 gene (3q25.33), encoding an intraflagellar transport protein, have recently been identified in a subset of patients. Mutations in several other genes may also be implicated in the disease but remain to be identified. The diagnosis is based on radiologic findings: ribs are short and the pelvis has an abnormal morphology, with a horizontal acetabular roof and a trident aspect formed by a median protrusion and two lateral spurs. Hands are short with cone-shaped epiphyses in the phalanges and the metacarpal metaphyses are concave. The differential diagnosis should include thoracolaryngopelvic dysplasia, Ellis-van Creveld syndrome and paternal uniparental disomy of chromosome 14 (see these terms). Treatment consists of management of respiratory infections, which may lead to severe complications. Renal function should also be monitored. Prognosis is highly variable but the risk of severe complications decreases after 2 years of age.